These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34171261)

  • 1. Establishing novel roles of bifidocin LHA, antibacterial, antibiofilm and immunomodulator against Pseudomonas aeruginosa corneal infection model.
    Mahdi LH; Laftah AR; Yaseen KH; Auda IG; Essa RH
    Int J Biol Macromol; 2021 Sep; 186():433-444. PubMed ID: 34171261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial immunomodulatory and antibiofilm triple effect of Salivaricin LHM against Pseudomonas aeruginosa urinary tract infection model.
    Mahdi LH; Jabbar HS; Auda IG
    Int J Biol Macromol; 2019 Aug; 134():1132-1144. PubMed ID: 31136751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454.
    Yildirim Z; Johnson MG
    J Food Prot; 1998 Jan; 61(1):47-51. PubMed ID: 9708252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting bacterial colonization on catheters: Antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33.
    Ray Mohapatra A; Jeevaratnam K
    J Glob Antimicrob Resist; 2019 Dec; 19():85-92. PubMed ID: 30853461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.
    Howard JJ; Sturge CR; Moustafa DA; Daly SM; Marshall-Batty KR; Felder CF; Zamora D; Yabe-Gill M; Labandeira-Rey M; Bailey SM; Wong M; Goldberg JB; Geller BL; Greenberg DE
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137807
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
    McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
    J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454.
    Yildirim Z; Winters DK; Johnson MG
    J Appl Microbiol; 1999 Jan; 86(1):45-54. PubMed ID: 10030011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
    Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
    Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
    Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.
    Trøstrup H; Lerche CJ; Christophersen L; Jensen PØ; Høiby N; Moser C
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672877
    [No Abstract]   [Full Text] [Related]  

  • 16.
    S Al-Hazmi A; M Albeshi B; M Alsofyani E; Alherthi MN; Aljuaid MM; Alfifi OA; Alshaer RS; Alsaadi RS; M Alomery A; Almehmadi MM; Eid E; Hawash YA
    Pak J Biol Sci; 2020 Jan; 23(12):1676-1680. PubMed ID: 33274902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
    Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
    Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
    Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
    J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.